Drug intelligence / Profile preview

Vulniphan

Development stage
Unknown
Lead developer
Dr. Pfleger
Modality
Small Molecules
Administration
Topical, Vaginal
01

Overview

Vulniphan is a hormone-free medical device developed by Dr. Pfleger Arzneimittel for the treatment of vaginal dryness and the promotion of vaginal mucosa regeneration. It is available as an over-the-counter (OTC) product in the form of vaginal suppositories (ovula) and gel. The primary active ingredient is hyaluronic acid, which provides intensive moisture and supports the natural healing process of the vaginal epithelium. This is supplemented by plant extracts including *Centella asiatica* (Tiger grass), *Calendula officinalis* (marigold), *Melaleuca alternifolia* (tea tree oil), and *Aloe vera*. Vulniphan is indicated for managing vaginal atrophy and dystrophy caused by menopause, gynecological procedures, childbirth, or cancer treatments such as chemotherapy and radiation therapy.

Brand names
VulniphanVulniphan VaginalovulaVulniphan Vaginalgel

Beyond the preview

Go deeper on Vulniphan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vulniphan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call